Sin-soo S. Jeun

St. Vincent's Hospital
Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Next-generation sequencing (NGS) analysis and age-based survival comparison among glioblastoma (GBM) patients: a two-center cohort study.

Next-generation sequencing (NGS) analysis and age-based survival comparison among glioblastoma (GBM) patients: a two-center cohort study.

Journal: Acta neurochirurgica

Published: February 23, 2026

Long-acting IL-7 induces distinct transcriptomic features in peripheral T cells of patients with solid tumors.

Long-acting IL-7 induces distinct transcriptomic features in peripheral T cells of patients with solid tumors.

Journal: JCI insight

Published: December 17, 2025

Therapeutic Potential of Engineered Stem Cell Line with Chemokine Receptors and TRAIL/CD::UPRT in Glioblastoma Treatment.

Therapeutic Potential of Engineered Stem Cell Line with Chemokine Receptors and TRAIL/CD::UPRT in Glioblastoma Treatment.

Journal: Cancer research and treatment

Published: October 10, 2025

Targeted NGS-Based Mutational Signature Analysis in Hypermutated Gliomas: A Case-Centered Feasibility Assessment.

Targeted NGS-Based Mutational Signature Analysis in Hypermutated Gliomas: A Case-Centered Feasibility Assessment.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: August 26, 2025

Evaluating an immunotherapeutic approach to photodynamic therapy for glioblastoma.

Evaluating an immunotherapeutic approach to photodynamic therapy for glioblastoma.

Journal: Photodiagnosis and photodynamic therapy

Published: June 12, 2025

SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer's disease.

SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer's disease.

Journal: Translational neurodegeneration

Published: February 24, 2025

Photoimmuno-Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition.

Photoimmuno-Lure Nanoplatform for Enhancing T Cell Expansion in Glioblastoma via Synergistic Treatment of Photodynamic Therapy and Immune Checkpoint Inhibition.

Journal: Advanced healthcare materials

Published: February 17, 2025

Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification.

Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification.

Journal: Pituitary

Published: June 06, 2024

From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma.

From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma.

Journal: Cancer letters

Published: December 12, 2023

Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?

Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?

Journal: Journal of neuro-oncology

Published: October 13, 2023

Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.

Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 09, 2023

Delineation of three-dimensional tumor margins based on normalized absolute difference mapping via volumetric optical coherence tomography.

Delineation of three-dimensional tumor margins based on normalized absolute difference mapping via volumetric optical coherence tomography.

Journal: Scientific reports

Published: June 14, 2023

Showing 1-12 of 88

Last Updated: 09/26/2026